A small cohort of six critically ill COVID-19 patients hospitalised in Israel have been treated with a placenta-based cell-therapy and have all survived, according to initial data. Pluristem, a company based in Haifa who specialise in the development of human...
According to a recent study, a critically ill patient infected with the new coronavirus has made an astounding recovery after receiving umbilical cord stem cell therapy. What does the study say? After contracting COVID-19, the 65-year-old woman was reportedly...
The outbreak of a new coronavirus, COVID-19, has prompted many expectant parents to wonder whether it can pass from mother to child during pregnancy. Until recently, limited information was available regarding the effects of COVID-19 on pregnant women and their...
The World Health Organisation (WHO) has declared Coronavirus (aka COVID-19) a “public health emergency of international concern”. With the number of cases continuing to increase and no vaccine or specific antiviral treatment currently available, finding a safe and...
You may have heard about the Cells4Life ASA ruling on some claims we make in our marketing materials. Specifically, the claim that our TotiCyte processing method preserves 3 times more stem cells than our competitor’s systems. This claim is based on extensive...
This month, we celebrate achieving AABB accreditation – a globally renowned certification that recognises standards, practices and quality management in the collection, processing and storage of cord blood. This is just the latest quality standard that we’ve attained....
Cord Blood Cell Therapy Shows Promise in Lymphoma Treatment
